Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy Model.

Nagata Y, Yamamoto T, Hayashi M, Hayashi S, Kadowaki M.

PLoS One. 2017 Jan 20;12(1):e0170577. doi: 10.1371/journal.pone.0170577. eCollection 2017.


Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.

Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP.

J Allergy Clin Immunol. 2017 Mar;139(3):882-888.e5. doi: 10.1016/j.jaci.2016.07.030. Epub 2016 Sep 5.


Diagnosis and treatment of pediatric food allergy: an update.

Comberiati P, Cipriani F, Schwarz A, Posa D, Host C, Peroni DG.

Ital J Pediatr. 2015 Feb 19;41:13. doi: 10.1186/s13052-014-0108-0.


IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.

Santos AF, James LK, Bahnson HT, Shamji MH, Couto-Francisco NC, Islam S, Houghton S, Clark AT, Stephens A, Turcanu V, Durham SR, Gould HJ, Lack G.

J Allergy Clin Immunol. 2015 May;135(5):1249-56. doi: 10.1016/j.jaci.2015.01.012. Epub 2015 Feb 7.


Developing therapies for peanut allergy.

Bublin M, Breiteneder H.

Int Arch Allergy Immunol. 2014;165(3):179-94. doi: 10.1159/000369340. Epub 2014 Dec 20. Review.


A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, Wood RA.

J Allergy Clin Immunol. 2015 May;135(5):1275-82.e1-6. doi: 10.1016/j.jaci.2014.11.005. Epub 2014 Dec 18.


Current opinion and review on peanut oral immunotherapy.

Deol S, Bird JA.

Hum Vaccin Immunother. 2014;10(10):3017-21. doi: 10.4161/hv.32190. Review.


Oral immunotherapy for the treatment of food allergy.

Begin P, Chinthrajah RS, Nadeau KC.

Hum Vaccin Immunother. 2014;10(8):2295-302. doi: 10.4161/hv.29233. Review.


Diagnosis and management of food allergies: new and emerging options: a systematic review.

O'Keefe AW, De Schryver S, Mill J, Mill C, Dery A, Ben-Shoshan M.

J Asthma Allergy. 2014 Oct 24;7:141-64. doi: 10.2147/JAA.S49277. eCollection 2014. Review.


Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy.

McGowan EC, Wood RA.

Curr Allergy Asthma Rep. 2014 Dec;14(12):486. doi: 10.1007/s11882-014-0486-9. Review.


Peanut immunotherapy.

Anagnostou K, Clark A.

Clin Transl Allergy. 2014 Sep 25;4:30. doi: 10.1186/2045-7022-4-30. eCollection 2014. Review.


Prolonged ingestion of ovalbumin diet by sensitized mice improves the metabolic consequences induced by experimental food allergy.

Batista NV, Pereira RV, Noviello ML, Dourado LP, Perez DA, Foureaux G, Ferreira AJ, Ferreira AV, Cara DC.

Clin Exp Immunol. 2014 Dec;178(3):416-27. doi: 10.1111/cei.12435.


Oral Immunotherapy for Treatment of Immunoglobulin E-Mediated Food Allergy: The Transition to Clinical Practice.

Pajno GB, Cox L, Caminiti L, Ramistella V, Crisafulli G.

Pediatr Allergy Immunol Pulmonol. 2014 Jun 1;27(2):42-50. Review.


Emerging therapies for food allergy.

Keet CA, Wood RA.

J Clin Invest. 2014 May;124(5):1880-6. doi: 10.1172/JCI72061. Epub 2014 May 1. Review.


Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O'Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC.

Allergy Asthma Clin Immunol. 2014 Feb 20;10(1):7. doi: 10.1186/1710-1492-10-7.


Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.

Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A.

Lancet. 2014 Apr 12;383(9925):1297-304. doi: 10.1016/S0140-6736(13)62301-6. Epub 2014 Jan 30.


Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.

Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC.

Allergy Asthma Clin Immunol. 2014 Jan 15;10(1):1. doi: 10.1186/1710-1492-10-1. Erratum in: Allergy Asthma Clin Immunol. 2016;12:28.


A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT.

J Allergy Clin Immunol. 2013 Dec;132(6):1368-74. doi: 10.1016/j.jaci.2013.09.046. Epub 2013 Oct 28.


Prolonged antigen ingestion by sensitized mice ameliorates airway inflammation.

Noviello Mde L, Batista NV, Dourado LP, Cara DC.

ISRN Allergy. 2011 Dec 1;2011:818239. doi: 10.5402/2011/818239. Print 2011.


Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.

Vickery BP, Lin J, Kulis M, Fu Z, Steele PH, Jones SM, Scurlock AM, Gimenez G, Bardina L, Sampson HA, Burks AW.

J Allergy Clin Immunol. 2013 Jan;131(1):128-34.e1-3. doi: 10.1016/j.jaci.2012.10.048. Epub 2012 Nov 27.

Supplemental Content

Support Center